Pipeline

women shaking hands during partnership agreement
 
Well-rounded

Recent acquisitions and our ongoing expansion efforts have laid the groundwork for a robust product pipeline. With an accelerated commitment to enhancing our capabilities with additional dose forms and a focus on novel development and ANDA manufacturing, our pipeline is well-rounded and continues to grow.

 


There's plenty on the horizon for Chartwell Pharmaceuticals LLC:



Multiple ANDAs
in development

3 ANDAs
pending filing

Capabilities for additional dosage forms currently being built out

Development of additional 505(b)(2) products underway



Explore our existing portfolio by visiting the Generics Catalog and reading more about our Branded Products.
Chartwell Pharmaceuticals
Well-Done.